Hyflux Ltd
SGX:600
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hyflux Ltd
SGX:600
|
SG |
|
Ceapro Inc
XTSX:CZO
|
CA |
|
E
|
Envela Corp
AMEX:ELA
|
US |
|
Surgical Innovations Group PLC
LSE:SUN
|
UK |
|
Victoria Insurance Tbk PT
IDX:VINS
|
ID |
|
Jeil Pharma Holdings Inc
KRX:002620
|
KR |
|
Guanghui Energy Co Ltd
SSE:600256
|
CN |
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
VN |
|
Grupo Aeroportuario del Sureste SAB de CV
BMV:ASURB
|
MX |
|
Shanghai International Port Group Co Ltd
SSE:600018
|
CN |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
T
|
Thomas Scott (India) Ltd
NSE:THOMASCOTT
|
IN |
|
I
|
IGS Capital Group Ltd
OTC:IGSC
|
MY |
|
U-Next Holdings Co Ltd
OTC:USNNF
|
JP |
|
A
|
Adocia SA
PAR:ADOC
|
FR |
|
C
|
Catalyst Bancorp Inc
NASDAQ:CLST
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hyflux Ltd's stock price target?
Not Available
Hyflux Ltd doesn't have any price targets made by Wall Street professionals.
What is Hyflux Ltd's Revenue forecast?
Projected CAGR
71%
For the last 13 years the compound annual growth rate for Hyflux Ltd's revenue is 11%. The projected CAGR for the next 1 year is 71%.
What is Hyflux Ltd's Operating Income forecast?
Projected CAGR
173%
For the last 13 years the compound annual growth rate for Hyflux Ltd's operating income is -3%. The projected CAGR for the next 1 year is 173%.